MCP
WGS icon

Meridiem Capital Partners’s GeneDx Holdings WGS Stock Holding History

Meridiem Capital Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Sell
46,764
-8,821
-16% -$501K 0.14% 82
2026
Q1 		$3.57M Buy
55,585
+34,778
+167% +$3.17M 0.23% 63
2025
Q4 		$2.71M Buy
+20,807
New +$2.86M 0.16% 68
2025
Q2 		– Sell
-19,271
Closed -$1.71M – 98
2025
Q1 		$1.71M Buy
+19,271
New +$1.67M 0.18% 55

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Meridiem Capital Partners's WGS Position: Q2 2026 in Review

Meridiem Capital Partners reduced its GeneDx Holdings (WGS) stake by 16% in Q2 2026, selling an estimated $501K and leaving 46,764 shares worth $3.21M. The position accounts for 0.14% of the portfolio, ranked #82.

Meridiem Capital Partners first reported a position in WGS in Q1 2025 and has held it in 4 quarters since. The position peaked at $3.57M in Q1 2026. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Meridiem Capital Partners held 46,764 shares of GeneDx Holdings worth $3.21M as of Q2 2026.
  • Meridiem Capital Partners sold 8,821 GeneDx Holdings shares in Q2 2026, an estimated $501K.
  • GeneDx Holdings made up 0.14% of Meridiem Capital Partners's portfolio in Q2 2026, its #82 holding.
  • Meridiem Capital Partners first reported a position in GeneDx Holdings in Q1 2025 and has held it in 4 quarters since.
  • Meridiem Capital Partners's GeneDx Holdings position peaked at $3.57M in Q1 2026.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.